The reality of multiple sclerosis assessment in middle-income countries.
Lancet Neurol. 2022 Mar;21(3):215. doi: 10.1016/S1474-4422(22)00042-4.
Lancet Neurol. 2022.
PMID: 35182501
No abstract available.